C1QTNF3 and fatty liver disease: In an experimental animal model, both CTRP3 overexpression and daily CTRP3 administration were effective in regulating high-fat diet-induced hepatic insulin resistance and hepatic steatosis [43], but not in mice fed a low-fat diet [43,44].